ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma

Niu, Xiang-Ke; He, Xiao-Feng*南方医科大学
WORLD JOURNAL OF GASTROENTEROLOGY2021-1-14DOI: 10.3748/wjg.v27.i2.189
19被引10阅读
引用收藏
分享

摘要

BACKGROUND @@@ Some patients with hepatocellular carcinoma (HCC) are more likely to experience disease progression despite continuous transarterial chemoembolization (TACE), which is called TACE refractoriness. At present, it is still difficult to predict TACE refractoriness, although some models/scoring systems have been developed. At present, radiological-based radiomics models have been successfully applied to predict cancer patient prognosis. @@@ AIM @@@ To develop and validate a computed tomography (CT)-based radiomics nomogram for the pre-treatment prediction of TACE refractoriness. @@@ METHODS @@@ This retrospective study consisted of a training dataset (n = 137) and an external validation dataset (n = 81) of patients with clinically/pathologically confirmed HCC who underwent repeated TACE from March 2009 to March 2016. Radiomics features were retrospectively extracted from preoperative CT images of the arterial phase. The pre-treatment radiomics signature was generated using least absolute shrinkage and selection operator Cox regression analysis. A CT-based radiomics nomogram incorporating clinical risk factors and the radiomics signature was built and verified by calibration curve and decision curve analyses. The usefulness of the CT-based radiomics nomogram was assessed by Kaplan-Meier curve analysis. We used the concordance index to conduct head-to-head comparisons of the radiomics nomogram with the other four models (Assessment for Retreatment with Transarterial Chemoembolization score; alpha-fetoprotein, Barcelona Clinic Liver Cancer, Child-Pugh, and Response score; CT-based radiomics signature; and clinical model). All analyses were conducted according to the transparent reporting of a multivariable prediction model for individual prognosis or diagnosis statement. @@@ RESULTS @@@ The median duration of follow-up was 61.3 mo (interquartile range, 25.5-69.3 mo) for the training cohort and 67.1 mo (interquartile range, 32.4-71.3 mo) for the validation cohort. The median number of TACE sessions was 4 (range, 3-7) in both cohorts. Eight radiomics features were chosen from 869 candidate features to build a radiomics signature. The CT-based radiomics nomogram included the radiomics score (hazard ratio = 3.9, 95% confidence interval: 3.1-8.8, P < 0.001) and four clinical factors and classified patients into high-risk (score > 3.5) and low-risk (score <= 3.5) groups with markedly different prognoses (overall survival: 12.3 mo vs 23.6 mo, P < 0.001). The accuracy of the nomogram was considerably higher than that of the other four models. The calibration curve and decision curve analyses verified the usefulness of the CT-based radiomics nomogram for clinical practice. @@@ CONCLUSION @@@ The newly constructed CT-based radiomics nomogram can be used for the pre-treatment prediction of TACE refractoriness, which may provide better guidance for decision making regarding further TACE treatment.

学科与关键词

关键词
Hepatocellular carcinomaTransarterial chemoembolizationRefractorinessRadiomicsNomogramComputed tomography
相关
加载中…
  • Prediction of early recurrence of hepatocellular carcinoma after liver transplantation based on computed tomography radiomics nomogram
    Zhao, Jing-Wei; Shu, Xin; Chen, Xiao-Xia; Liu, Jia-Xiong; Liu, Mu-Qing; Ye, Ju; Jiang, Hui-Jie; Wang, Gui-Sheng*Hepatobiliary & Pancreatic Diseases International, 2022, 21(6): 543-550.被引 4
  • Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study
    Wang, Dan-Dan; Zhang, Jin-Feng; Zhang, Lin-Han; Niu, Meng; Jiang, Hui-Jie*; Jia, Fu-Cang*; Feng, Shi-Ting*Hepatobiliary & Pancreatic Diseases International, 2023, 22(6): 594-604.被引 2
  • Development and validation of a clinical-radiomics model to predict recurrence for patients with hepatocellular carcinoma after curative resection
    Ren, Yiyue; Bo, Linlin; Shen, Bo; Yang, Jing; Xu, Shufeng; Shen, Weiqiang; Chen, Hao; Wang, Xiaoyan; Chen, Haipeng; Cai, Xiujun*Medical Physics, 2023, 50(2): 778-790.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
WORLD JOURNAL OF GASTROENTEROLOGY
发表日期
2021-01-14
卷期
第 27 卷, 第 2 期
页码
189-207
DOI
10.3748/wjg.v27.i2.189
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
Health and Family Planning Commission of Sichuan Province, China [17PJ430, 18PJ150]

作者

  • N

    Niu, Xiang-Ke (第一作者)

    chengdu univ · southern med univ

  • H

    He, Xiao-Feng (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417